ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer
A recent study in mice reveals that targeting ENPP1 could enhance immunotherapy effectiveness, offering hope for better breast cancer treatment outcomes. In Forbes:
